The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations
Open accessAbstract
ETHNOPHARMACOLOGICAL RELEVANCE Coptidis rhizoma (huanglian) and its major component, berberine, have drawn extensive attention toward their antineoplastic effects in the recent years. The antineoplastic effects are related to the Chinese Medicine (CM) properties of huanglian in treating diseases by removing damp-heat and purging fire and counteracting toxicity. AIM OF THE REVIEW To trace the long history of the traditional use of huanglian from folk medicines, especially from Chinese medicine, to recent pharmacological studies of huanglian and berberine, with an emphasis on their antineoplastic effects and the promise as novel antineoplastic agents. METHODS A total of seven databases were extensively searched for literature research. The terms and keywords for searching included huanglian, berberine, Coptis, Coptidis rhizoma, anticancer, anti-invasion, antimatastasis and mechanism. The papers including ours with studies on anticancer and mechanism, pharmacology and toxicology of huanglian and/or berberine were focused. RESULTS In view of traditional use, the anticancer effects of huanglian can be ascribed to its CM trait by removing damp-heat, fire and toxicity. From modern biomedical studies, anticancer effects have been demonstrated in both huanglian and berberine. The underlying molecular mechanisms involve cell-cycle arrest, apoptosis induction and anti-inflammation. Berberine is an essential anticancer compound in huanglian. In some studies, the use of huanglian was shown to be more effective and beneficial than the use of berberine alone. The presence of other protoberberine-type alkaloids in huanglian might give synergistic effects for the anticancer effects. Berberine also demonstrates effects of antiangiogenesis, anti-invasion and anti-metastasis in some cancer cell lines, however, more investigations are required to unravel the underlying mechanisms involved. CONCLUSIONS The modern evidences of treating cancer with huanglian and berberine have a strong linkage with traditional concept and rules of using huanglian in CM practice. As anticancer candidates with low toxicity, berberine and its altered structure, as well as huanglian and its formulae, will attract scientists to pursue the potential anticancer effects and the mechanisms by using technologies of genomics, proteomics and other advanced approaches. On the other hand, relatively few in vivo studies have been conducted on anticancer effects of huanglian and berberine. The clinical application of berberine or huanglian as novel cancer therapeutic agents requires in vivo validations and further investigations of their anticancer mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mantena, S. K., Sharma, S. D., & Katiyar, S. K. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl043 · Cited by 174
RetractedCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
McCullough, K. D., Martindale, J. L., Klotz, L.-O., Aw, T.-Y., & Holbrook, N. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1249-1259.2001 · Cited by 1,889
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1135 · Cited by 1,391
Self-citationInflammation and cancer: An ancient link with novel potentials
Perwez Hussain, S., & Harris, C. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23173 · Cited by 1,097
Inflammation, a Key Event in Cancer Development
Lu, H., Ouyang, W., & Huang, C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0261 · Cited by 1,028
Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., & Lewis, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030540597 · Cited by 761
The anti-inflammatory potential of berberine in vitro and in vivo
Kuo, C.-L., Chi, C.-W., & Liu, T.-Y. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.09.002 · Cited by 685
Reed, J. C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd726 · Cited by 643
Quaternary protoberberine alkaloids
Grycová, L., Dostál, J., & Marek, R. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2006.10.004 · Cited by 424
Chien, Y., Kim, S., Bumeister, R., Loo, Y.-M., Kwon, S. W., Johnson, C. L., Balakireva, M. G., Romeo, Y., Kopelovich, L., Gale, M., et al. (2006) · Cell · doi:10.1016/j.cell.2006.08.034 · Cited by 368
Mantena, S. K., Sharma, S. D., & Katiyar, S. K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0448 · Cited by 353
Berberine sulfate: antimicrobial activity, bioassay, and mode of action
Amin, A. H., Subbaiah, T. V., & Abbasi, K. M. (1969) · Canadian Journal of Microbiology · doi:10.1139/m69-190 · Cited by 298
Zuo, F., Nakamura, N., Akao, T., & Hattori, M. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011361 · Cited by 281
Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells
Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., & Fujiwara, H. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00162-7 · Cited by 270
NF‐κB as a potential molecular target for cancer therapy
Lee, C. H., Jeon, Y., Kim, S., & Song, Y. (2007) · BioFactors · doi:10.1002/biof.5520290103 · Cited by 248
Registry of toxic effects of chemical substances
Sweet, D. V. (1987) · Medical Entomology and Zoology · Cited by 227
Rabbani, G. H., Butler, T., Knight, J., Sanyal, S. C., & Alam, K. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.5.979 · Cited by 214
Inaugural Article: Metabolic engineering of plant alkaloid biosynthesis
Sato, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011526398 · Cited by 208
Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells
Hwang, J. M., Kuo, H. C., Tseng, T. H., Liu, J. Y., & Chu, C. Y. (2006) · Archives of Toxicology · doi:10.1007/s00204-005-0014-8 · Cited by 204
Pandey, M. K., Sung, B., Kunnumakkara, A. B., Sethi, G., Chaturvedi, M. M., & Aggarwal, B. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0511 · Cited by 200
Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts
Wang, S., Zheng, Z., Weng, Y., Yu, Y., Zhang, D., Fan, W., Dai, R., & Hu, Z. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.03.005 · Cited by 194
Letašiová, S., Jantová, S., Čipák, L., & Múčková, M. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.08.024 · Cited by 189
Berberine stimulates glucose transport through a mechanism distinct from insulin
Zhou, L., Yang, Y., Wang, X., Liu, S., Shang, W., Yuan, G., Li, F., Tang, J., Chen, M., & Chen, J. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.025 · Cited by 187
Self-citationMeeran, S. M., Katiyar, S., & Katiyar, S. K. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.12.027 · Cited by 184
Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells
Jantová, S., čipák, L., čerňáková, M., & Košt‘álová, D. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235703322277186 · Cited by 176
Ho, Y.-T., Yang, J., Li, T., Lin, J., Lin, J., Lai, K., Ma, C.-Y., Wood, W. G., & Chung, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.033 · Cited by 170
Iizuka, N., Miyamoto, K., Okita, K., Tangoku, A., Hayashi, H., Yosino, S., Abe, T., Morioka, T., Hazama, S., & Oka, M. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00264-5 · Cited by 170
Antiviral activity of berberine and related compounds against human cytomegalovirus
Hayashi, K., Minoda, K., Nagaoka, Y., Hayashi, T., & Uesato, S. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.085 · Cited by 164
日本公定書協会 (2001) · Medical Entomology and Zoology · Cited by 163
Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line
Lin, J.-P., Yang, J.-S., Lee, J.-H., Hsieh, W.-T., & Chung, J.-G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i1.21 · Cited by 159
Inhibition of chemical carcinogenesis by berberine in rats and mice
Anis, K. V., Rajeshkumar, N. V., & Kuttan, R. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775901 · Cited by 159
Hsu, W.-H., Hsieh, Y.-S., Kuo, H.-C., Teng, C.-Y., Huang, H.-I., Wang, C.-J., Yang, S.-F., Liou, Y.-S., & Kuo, W.-H. (2007) · Archives of Toxicology · doi:10.1007/s00204-006-0169-y · Cited by 159
Peng, P.-L., Hsieh, Y., Wang, C., Hsu, J., & Chou, F. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.11.010 · Cited by 155
Katiyar, S. K., Meeran, S. M., Katiyar, N., & Akhtar, S. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20453 · Cited by 148
Liu, Z., Liu, Q., Xu, B., Wu, J., Guo, C. H., Zhu, F., Yang, Q., Gao, G., Gong, Y., & Shao, C. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.12.009 · Cited by 146
The Effect of Berberine Chloride on Experimental Colitis in Rats In Vivo and In Vitro
Zhou, H., & Mineshita, S. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39141-4 · Cited by 145
Kim, S., Choi, J. H., Kim, J. B., Nam, S. J., Yang, J., Kim, J., & Lee, J. E. (2008) · Molecules · doi:10.3390/molecules13122975 · Cited by 140
Peng, P.-L., Kuo, W., Tseng, H., & Chou, F. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.08.034 · Cited by 139
Berberine Inhibits HIF-1α Expression via Enhanced Proteolysis
Lin, S., Tsai, S.-C., Lee, C.-C., Wang, B.-W., Liou, J.-Y., & Shyu, K. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05644-x · Cited by 138
9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA
Zhang, W., Ou, T., Lu, Y., Huang, Y.-Y., Wu, W., Huang, Z., Zhou, J.-L., Wong, K., & Gu, L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.05.050 · Cited by 135
Lin, C., Ng, L., Hsu, F.-F., Shieh, D., & Chiang, L. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2004.03951.x · Cited by 132
Lee, C.-H., Chen, J., Hsiang, C., Wu, S., Wu, H.-C., & Ho, T. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.06.003 · Cited by 129
Possible Toxicity of Herbal Remedies
Bateman, J. M., Chapman, R., & Simpson, D. (1998) · Scottish Medical Journal · doi:10.1177/003693309804300104 · Cited by 126
Berberine inhibits HIF-1alpha expression via enhanced proteolysis.
Lin, S., Tsai, S.-C., Lee, C.-C., Wang, B.-W., Liou, J.-Y., & Shyu, K. (2004) · PubMed · Cited by 119
Nucleophosmin Sets a Threshold for p53 Response to UV Radiation
Maiguel, D. A., Jones, L., Chakravarty, D., Yang, C., & Carrier, F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.9.3703-3711.2004 · Cited by 115
Inhibition of Activator Protein 1 Activity by Berberine in Human Hepatoma Cells
Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., & Fujiwara, H. (1999) · Planta Medica · doi:10.1055/s-2006-960795 · Cited by 112
Rojsanga, P., Sukhthankar, M., Gritsanapan, W., & Baek, S. J. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.09.007 · Cited by 112
Choi, M. S., Oh, J. H., Kim, S. M., Jung, H. Y., Yoo, H. S., Lee, Y., Moon, D. C., Han, S., & Hong, J. T. (2009) · PubMed · Cited by 110
Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells
Jantová, S., Čipák, L., & Letašiová, S. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.07.015 · Cited by 109
Displacement of Bilirubin from Albumin by Berberine
Chan, E. (2009) · Biology of the Neonate · doi:10.1159/000243932 · Cited by 107
Li, X.-K., Motwani, M., Tong, W. P., Bornmann, W. G., & Schwartz, G. K. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12699-5 · Cited by 105
Lin, H.-L., Liu, T.-Y., Wu, C.-W., & Chi, C.-W. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690710 · Cited by 100
Lin, T., Kuo, H., Chou, F., & Lu, F. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-58 · Cited by 99
Wang, X.-N., Han, X., Xu, L., Yin, L.-H., Xu, Y., Qi, Y., & Peng, J. (2008) · Phytomedicine · doi:10.1016/j.phymed.2008.05.002 · Cited by 96
Kang, J. X., Liu, J., Wang, J., He, C., & Li, F. P. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi154 · Cited by 96
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death
Kerr, L. E., Birse-Archbold, J.-L. A., Short, D. M., McGregor, A. L., Héron, I., MacDonald, D. C., Thompson, J.-L., Carlson, G. J., Kelly, J. S., McCulloch, J., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1210044 · Cited by 94
Thirupurasundari, C. J., PADMINI, R., & Devaraj, S. N. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.09.027 · Cited by 94
Lin, C. C., Lin, S. Y., Chung, J., Lin, J., Chen, G. W., & Kao, S. T. (2006) · PubMed · Cited by 93
Developmental toxicity evaluation of berberine in rats and mice
Jahnke, G. D., Price, C. J., Marr, M. C., Myers, C. B., & George, J. D. (2006) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20075 · Cited by 84
Lin, C. C., Kao, S. T., Chen, G. W., Ho, H.-C., & Chung, J. (2006) · PubMed · Cited by 83
Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model
Ho, Y.-T., Yang, J., Lu, C., et al. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.02.015 · Cited by 83
Eom, K., Hong, J.-M., Youn, M., So, H., Park, R., Kim, J., & Kim, T. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.558 · Cited by 83
Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis.
Choi, M. S., Yuk, D. Y., Oh, J. H., Jung, H. Y., Han, S., Moon, D. C., & Hong, J. T. (2008) · PubMed · Cited by 80
Liu, J., He, C., Zhou, K., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.169 · Cited by 80
Iizuka, N., Miyamoto, K., Hazama, S., Yoshino, S., Yoshimura, K., Okita, K., Fukumoto, T., Yamamoto, S., Tangoku, A., & Oka, M. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00496-1 · Cited by 67
Iizuka, N., Oka, M., Yamamoto, K. T., Tangoku, A., Miyamoto, K., Miyamoto, T., Uchimura, S., Hamamoto, Y., & Okita, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11452 · Cited by 58
In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines.
Kettmann, V., Kosfálová, D., Jantová, S., Čerňáková, M., & Drimal, J. (2004) · PubMed · Cited by 52
Study of some pharmacological actions of berberine.
Sabir, M., & Nk, B. (1971) · PubMed · Cited by 49
Berberine inhibits WEHI-3 leukemia cells in vivo.
Yu, F.-S., Yang, J., Lin, H.-J., Yu, C.-S., Tan, T., Lin, Y.-T., Lin, C.-C., Lu, H. F., & Chung, J. (2007) · PubMed · Cited by 47
Jagetia, G. C., & Baliga, M. S. (2004) · Journal of Medicinal Food · doi:10.1089/1096620041224094 · Cited by 44
Fell, D. A. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02521-5 · Cited by 44
Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model
Kettmann, V., Košťálová, D., & Höltje, H. (2004) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-004-7878-1 · Cited by 43
Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines.
Inoue, K., Kulsum, U., Chowdhury, S. A., Fujisawa, S., Ishihara, M., Yokoe, I., & Sakagami, H. (2005) · PubMed · Cited by 39
Issat, T., Jakóbisiak, M., & Gołąb, J. (2006) · Oncology Reports · doi:10.3892/or.16.6.1273 · Cited by 33
Ohta, Y., Kongo, M., Hayashi, T., & Kishikawa, T. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.06.004 · Cited by 32
Molecular dissection of a medicinal herb with anti-tumor activity by oligonucleotide microarray
Hara, A., Iizuka, N., Hamamoto, Y., Uchimura, S., Miyamoto, T., Tsunedomi, R., Miyamoto, K., Hazama, S., Okita, K., & Oka, M. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.01.018 · Cited by 32
Molecular determinants of response of tumor cells to berberine
Efferth, T., Chen, Z., Kaina, B., & Gan, W. (2005) · Cancer Genomics & Proteomics · Cited by 23
[Advances in the study of berberine and its derivatives].
Li, B., Zhu, W., & Chen, K. (2008) · PubMed · Cited by 23
Lin, C. C., Kao, S. T., Chen, G. W., & Chung, J. (2005) · PubMed · Cited by 22
Cited by
Zhang, X., Zhao, Y., Xu, J., Xue, Z., Zhang, M., Pang, X., Zhang, X., & Zhao, L. (2015) · Scientific Reports · doi:10.1038/srep14405 · Cited by 630
Zhang, X., Zhao, Y., Zhang, M., Pang, X., Xu, J., Kang, C., Li, M., Zhang, C., Zhang, Z., Zhang, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042529 · Cited by 615
“treat intestinal infections, particularly bacterial diarrhea, for thousands of years in China [14].”
BackgroundInfluentialNeag, M. A., Mocan, A., Echeverría, J., Pop, R. M., Bocsan, C. I., Crişan, G., & Buzoianu, A. D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00557 · Cited by 562
The metabolism of berberine and its contribution to the pharmacological effects
Wang, K., Feng, X., Chai, L., Cao, S., & Qiu, F. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2017.1306544 · Cited by 502
Berberine: New perspectives for old remedies
Tillhon, M., Guamán Ortiz, L. M., Lombardi, P., & Scovassi, A. I. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.018 · Cited by 477
Metadata
- Authors
- Tang, J., Feng, Y., Tsao, S., Wang, N., Curtain, R., & Wang, Y.
- Venue
- Journal of Ethnopharmacology
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 126
- Issue
- 1
- Pages
- 5-17
- ISSN
- 0378-8741 (ISSN-L)
- OpenAlex
- W2088154315
- Cited by
- 491
- References
- 82
- FWCI
- 17.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.